AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) Estimate
AEON Biopharma (AMEX:AEON) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.12) by 83.33 percent. This is a 96.67 percent increase over losses of $(0.60) per share from the
